Related Articles
68Ga-PSMA PET/CT for the detection of bone metastasis in recurrent prostate cancer and a PSA level <2 ng/ml: Two case reports and a literature review
Development of a 124I-labeled version of the anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer: Aspects of labeling chemistry and biodistribution
Diagnostic performance of <sup>18</sup>F‑DCFPyL PET vs. <sup>68</sup>Ga‑PSMA PET/CT in patients with suspected prostate cancer: A systemic review and meta‑analysis
Diagnostic role of fluorodeoxyglucose positron emission tomography‑computed tomography in prostate cancer
Preferential association of prostate cancer cells expressing prostate specific membrane antigen to bone marrow matrix